The global healthcare industry has entered an era where innovation is not just about profit — it’s about purpose. Nowhere is this more evident than in the rare disease drugs market, a sector dedicated to addressing the unmet medical needs of millions of patients suffering from conditions that affect only a small fraction of the population. Despite their rarity, these diseases...